SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression
Authors:
- Hortensia ÁlvarezHÁHortensia Álvarez
- Ezequiel Ruiz-MateosEREzequiel Ruiz-Mateos
- Pedro Miguel Juiz-GonzálezPJPedro Miguel Juiz-González
- Joana VitalléJVJoana Vitallé
- Irene ViéitezIVIrene Viéitez
- María del Carmen Vázquez-FriolMVMaría del Carmen Vázquez-Friol
- Isabel Torres-BeceiroITIsabel Torres-Beceiro
- Alberto Pérez-GómezAPAlberto Pérez-Gómez
- Pilar Gallego-GarcíaPGPilar Gallego-García
- Nuria Estévez-GómezNENuria Estévez-Gómez
- Loretta De ChiaraLCLoretta De Chiara
- Eva PovedaEva Poveda
Open Access
- 11 January 2022
- journal article
- case report
- Published by MDPI AG in Microorganisms
- Vol. 10 (1) , 143
Abstract
Intra-host evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported in cases with persistent coronavirus disease 2019 (COVID-19). In this study, we describe a severely immunosuppressed individual with HIV-1/SARS-CoV-2 coinfection with a long-term course of SARS-CoV-2 infection. A 28-year-old man was diagnosed with HIV-1 infection (CD4+ count: 3 cells/µL nd 563000 HIV-1 RNA copies/mL) and simultaneous Pneumocystis jirovecii pneumonia, disseminated Mycobacterium avium complex infection and SARS-CoV-2 infection. SARS-CoV-2 real-time reverse transcription polymerase chain reaction positivity from nasopharyngeal samples was prolonged for 15 weeks. SARS-CoV-2 was identified as variant Alpha (PANGO lineage B.1.1.7) with mutation S:E484K. Spike-specific T-cell response was similar to HIV-negative controls although enriched in IL-2, and showed disproportionately increased immunological exhaustion marker levels. Despite persistent SARS-CoV-2 infection, adaptive intra-host SARS-CoV-2 evolution, was not identified. Spike-specific T-cell response protected against a severe COVID-19 outcome and the increased immunological exhaustion marker levels might have favoured SARS-CoV-2 persistence.Keywords
This publication has 48 references indexed in Scilit:
- Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—SupercontrollersFrontiers in Immunology, 2018
- First reported case of integrase (R263K, G163R) and reverse transcriptase (M184V)-transmitted drug resistance from a drug-naive patient failing TriumeqAIDS, 2018
- Emergence of Integrase Resistance Mutations During Initial Therapy Containing DolutegravirClinical Infectious Diseases, 2018
- Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitorsAIDS, 2018
- Emergent drug resistance with integrase strand transfer inhibitor-based regimensAIDS, 2017
- Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samplesNature Protocols, 2017
- CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ARTPLOS Pathogens, 2016
- High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment responseAIDS, 2014
- Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite ControllersJournal of Virology, 2012
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009